Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

XenoPort shares drop 26% after failed trial
Marketwatch
Wednesday, July 7, 2010 - 12:16pm
tags:
XenoPort, GSK, migraines
Bristol-Myers' Orencia gets expanded use in Europe
Yahoo/AP
Wednesday, July 7, 2010 - 12:15pm
tags:
Bristol-Myers Squibb, Orencia, Europe, rheumatoid arthritis
FDA Nod for Shire Drug
Yahoo/Zacks.com
Wednesday, July 7, 2010 - 12:13pm
tags:
FDA, Shire, Daytrana, JNJ, Novartis, ADHD
Big Pharma's Mantra: Fail Early, Fail Fast
Seeking Alpha
Wednesday, July 7, 2010 - 12:12pm
tags:
Big Pharma, GSK, Pfizer, clinical trials
Top 10 Pharma CEO salaries of 2009
Fierce Pharma
Wednesday, July 7, 2010 - 9:55am
tags:
Pharma CEOs, executive pay
Biotech Milestones to Watch in Q3: Obesity Drugs, Genetic Testing and More
BNET Pharma
Wednesday, July 7, 2010 - 9:36am
tags:
Vivus, Qnexa, Myriad, Genomic Health, NicOx, naproxcinod, Savient, Krystexxa, Novartis, Gilenia, Seattle Genetics, Gilead Sciences, Chelsea Therapeutics, Eisai
A Medical Journal And A ‘Slick’ Paper About Niaspan
Pharmalot
Wednesday, July 7, 2010 - 9:29am
tags:
Niaspan, Abbott Laboratories
XenoPort, Glaxo Migrane Drug Fails To Outperform Placebo
WSJ Online
Wednesday, July 7, 2010 - 9:27am
tags:
XenoPort, GSK, migraines, clinical trials
Dendreon and Provenge: What if We Lived in England?
Seeking Alpha
Wednesday, July 7, 2010 - 9:05am
tags:
Dendreon, Provenge, England, vaccines, prostate cancer
Roche submits breast cancer drug for FDA approval
Reuters
Wednesday, July 7, 2010 - 8:59am
tags:
Roche, breast cancer, FDA, Trastuzumab-Dm1
Aspen Pharmacare Lowers its Sigma Takeover Offer Proposal by 8.3 Percent
Bloomberg
Wednesday, July 7, 2010 - 8:57am
tags:
Aspen, M&A, Sigma, Africa
Sex Diseases Tripled in Men 40 or Older Taking Viagra, Cialis, Study Says
Bloomberg
Wednesday, July 7, 2010 - 8:56am
tags:
Cialis, Viagra, Eli Lilly, Pfizer, erectile dysfunction
Dynavax gets grant for work on new HPV vaccine
Yahoo/AP
Wednesday, July 7, 2010 - 8:39am
tags:
HPV, Dynavax, vaccines, grants
How to Hitch Ride on Health-Care Investing
Yahoo/TheStreet.com
Wednesday, July 7, 2010 - 8:37am
tags:
GSK, JNJ, Novartis, Pfizer, Merck
Pfizer gets EU approval for cholesterol blockbuster Lipitor in children with high blood fats
Yahoo/AP
Wednesday, July 7, 2010 - 8:36am
tags:
Pfizer, pediatrics, Lipitor, cholesterol, Europe
I, Robot: Why a Pay Raise is Bad News for Novartis Sales Reps
BNET Pharma
Tuesday, July 6, 2010 - 5:34pm
tags:
sales reps, Novartis, drug reps
Rising From the Ashes of Pfizer: The Michigan Contract Research Organization Cluster
Motley Fool
Tuesday, July 6, 2010 - 3:48pm
tags:
Pfizer, CROs
Biotech Celgene Street’s Top 2nd-Half Pick
CNBC
Tuesday, July 6, 2010 - 2:09pm
tags:
Celgene
Vaccine Makers Accused Of Anticompetitive Pricing
Pharmalot
Tuesday, July 6, 2010 - 11:48am
tags:
drug pricing, vaccines, Sanofi Pasteur, FTC, Merck
EU backs Nycomed's Daxas in deadly lung disease
Reuters
Tuesday, July 6, 2010 - 11:46am
tags:
Europe, Daxas, Nycomed, COPD

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.